Adjusted HR (95% CI) for moderate/serious liver dysfunction. Models also adjusted for age and body mass index
| Women adjusted HR (95% CI) | Men adjusted HR (95% CI) | |
| Non-users of statins | 1.00 | 1.00 |
| New users of statins | 1.53 (1.41 to 1.66) | 1.53 (1.42 to 1.66) |
| Townsend score (5 unit increase) | 0.93 (0.98 to 0.99) | 1.02 (1.00 to 1.01) |
| Ethnicity | ||
| White or not recorded | 1.00 | 1.00 |
| Indian | 0.94 (0.7 to 1.26) | 1.16 (0.90 to 1.50) |
| Pakistani | 1.45 (1.05 to 2.00) | 1.18 (0.85 to 1.63) |
| Bangladeshi | 1.41 (0.8 to 2.50) | 1.31 (0.81 to 2.11) |
| Other Asian | 1.62 (1.1 to 2.39) | 1.43 (0.96 to 2.13) |
| Caribbean | 0.51 (0.34 to 0.76) | 0.86 (0.62 to 1.20) |
| Black African | 0.74 (0.49 to 1.12) | 0.56 (0.36 to 0.87) |
| Chinese | 1.40 (0.81 to 2.42) | 1.29 (0.73 to 2.28) |
| Other ethnic group | 0.94 (0.72 to 1.24) | 1.17 (0.93 to 1.49) |
| Smoking status | ||
| Non-smoker | 1.00 | 1.00 |
| Ex-smoker | 1.06 (1.00 to 1.13) | 1.14 (1.08 to 1.21) |
| Light smoker | 1.12 (1.01 to 1.24) | 1.21 (1.12 to 1.32) |
| Moderate smoker | 1.23 (1.13 to 1.34) | 1.19 (1.09 to 1.29) |
| Heavy smoker | 1.36 (1.23 to 1.51) | 1.34 (1.23 to 1.45) |
| Comorbidity | ||
| Type 1 diabetes | 2.15 (1.51 to 3.07) | 1.52 (1.09 to 2.13) |
| Type 2 diabetes | 1.13 (1.00 to 1.27) | 1.45 (1.31 to 1.60) |
| Cardiovascular disease | 1.14 (1.02 to 1.27) | 1.22 (1.11 to 1.34) |
| Treated hypertension | 1.23 (1.15 to 1.32) | 1.40 (1.31 to 1.51) |
| Rheumatoid arthritis | 2.42 (2.13 to 2.76) | 1.90 (1.53 to 2.36) |
| Corticosteroids | 1.47 (1.34 to 1.61) | 1.44 (1.29 to 1.62) |
Fractional polynomial terms women; age2, age2 ln(age), bmi3, bmi3ln(bmi), men age−2, age3, bmi−2, bmi−2 ln(bmi).